Why the study?
The long-term trajectory of blood pressure after acute ischemic stroke and its influence on outcomes have not been fully elucidated.
Does a slowly dropping systolic blood pressure trajectory increase the risk of adverse cardiovascular outcomes in patients with acute ischemic stroke?
Does a slowly dropping systolic blood pressure trajectory increase the risk of adverse cardiovascular outcomes in patients with acute ischemic stroke?
A slowly dropping systolic blood pressure trajectory during the first year after acute ischemic stroke is associated with a significantly higher risk of recurrent stroke, myocardial infarction, and mortality compared to a moderate trajectory.
Post-stroke SBP trajectories may refine long-term risk stratification; leaves open whether targeting them improves outcomes in trials.
Although the effect of blood pressure on post-stroke outcome is well-recognized, the long-term trajectory of blood pressure after acute ischemic stroke and its influence on outcomes have not yet been fully elucidated. From a multicenter prospective registry of acute ischemic stroke patients, 5,514 patients with measurements of systolic blood pressure (SBP) at more than 2 of 7 prespecified time-points, up to 1-year after stroke onset, were analyzed. Outcome measures, a composite of stroke recurrence, myocardial infarction and mortality, and each stroke recurrence and mortality, were prospectively collected up to 1-year after stroke onset. The study subjects were categorized into 4 groups according to their SBP trajectories: Low (27.0%), Moderate (59.5%), Persistently high (1.2%), and Slowly dropping (12.4%). After adjustments for pre-determined covariates, the Slowly dropping SBP Group was at higher risk of the composite outcome (hazard ratio, 1.32; 95% confidence interval, 1.05‒1.65), and mortality (1.35; 1.03‒1.78) compared to the Moderate SBP Group . Four main 1-year longitudinal SBP trajectories were identified after acute ischemic stroke. One trajectory, slowly dropping SBP, was particularly prone to adverse outcomes after stroke. These findings provide possible leads for future investigations of SBP control targets after stroke.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: